Structure-based investigation on the interaction of perfluorinated compounds with human liver fatty acid binding protein

Environmental Science and Technology

Volumn 47, Issue 19, 2013, Pages 11293-11301

  Zhang, Lianying ^a   Ren, Xiao Min ^a   Guo, Liang Hong ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EXPERIMENTAL ANIMALS; FATTY ACID-BINDING PROTEINS; FLUOROTELOMER ALCOHOLS; HYDROGEN BONDING INTERACTIONS; PERFLUORINATED CARBOXYLIC ACIDS; PERFLUORINATED COMPOUND (PFCS); PERFLUORINATED COMPOUNDS; PERFLUORINATED SULFONIC ACID;

BINDING ENERGY; HYDROGEN BONDS; PROTEINS;

FATTY ACIDS;

FATTY ACID BINDING PROTEIN; OLEIC ACID; PALMITIC ACID; PERFLUORINATED CARBOXYLIC ACID DERIVATIVE; PERFLUORINATED SULFONIC ACID DERIVATIVE; PERFLUORO COMPOUND; PERFLUOROBUTANE SULFONATE; PERFLUOROBUTYRIC ACID; PERFLUORODECANOIC ACID; PERFLUORODODECANOIC ACID; PERFLUOROHEPTANOIC ACID; PERFLUOROHEXADECANOIC ACID; PERFLUOROHEXANE SULFONATE; PERFLUOROHEXANOIC ACID; PERFLUORONONANOIC ACID; PERFLUOROOCTADECANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PERFLUOROPENTANOIC ACID; PERFLUOROTETRADECANOIC ACID; PERFLUOROUNDECANOIC ACID; UNCLASSIFIED DRUG;

CARBOXYLIC ACID; FATTY ACID; GEOMETRY; HYDROPHOBICITY; ORGANOFLUORINE; PROTEIN; TOXICITY;

ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; DISSOCIATION CONSTANT; HYDROGEN BOND; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; IC 50; LIVER; MOLECULAR DOCKING; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

ALKANESULFONIC ACIDS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FLUOROCARBONS; HUMANS;

EID: 84885114720     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es4026722     Document Type: Article

References (53)

1. Bjorklund, J. A.; Thuresson, K.; De Wit, C. A. Perfluoroalkyl compounds (PFCs) in indoor dust: concentrations, human exposure estimates, and sources Environ. Sci. Technol. 2009, 43, 2276-2281
2. Giesy, J. P.; Kannan, K. Perfluorochemical surfactants in the environment Environ. Sci. Technol. 2002, 36, 146A-152A
3. Houde, M.; Martin, J. W.; Letcher, R. J.; Solomon, K. R.; Muir, D. C. G. Biological monitoring of polyfluoroalkyl substances: A review Environ. Sci. Technol. 2006, 40, 3463-3473
4. Raymer, J. H.; Michael, L. C.; Studabaker, W. B.; Olsen, G. W.; Sloan, C. S.; Wilcosky, T.; Walmer, D. K. Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements Reprod. Toxicol. 2012, 33, 419-427
5. Conder, J. M.; Hoke, R. A.; De Wolf, W.; Russell, M. H.; Buck, R. C. Are PFCAs bioaccumulative? A critical review and comparison with regulatory lipophilic compounds Environ. Sci. Technol. 2008, 42, 995-1003
6. Nelson, J. W.; Hatch, E. E.; Webster, T. F. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general US population Environ. Health Perspect. 2010, 118, 197-202
7. Steenland, K.; Fletcher, T.; Savitz, D. A. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA) Environ. Health Perspect. 2010, 118, 1100-1108
8. Eriksen, K. T.; Sorensen, M.; McLaughlin, J. K.; Lipworth, L.; Tjonneland, A.; Overvad, K.; Raaschou-Nielsen, O. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population J. Natl. Cancer Inst. 2009, 101, 605-609
9. Gallo, V.; Leonardi, G.; Genser, B.; Lopez-Espinosa, M.-J.; Frisbee, S. J.; Karlsson, L.; Ducatman, A. M.; Fletcher, T. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated pfoa exposure Environ. Health Perspect. 2012, 120, 655-660
10. Lau, C.; Anitole, K.; Hodes, C.; Lai, D.; Pfahles-Hutchens, A.; Seed, J. Perfluoroalkyl acids: a review of monitoring and toxicological findings Toxicol. Sci. 2007, 99, 366-394
11. Thorsten, S.; Daniela, M.; Brunn, H. Toxicology of perfluorinated compounds Environ. Sci. Eur. 2011, 23, 1-52
12. Thibodeaux, J. R.; Hanson, R. G.; Rogers, J. M.; Grey, B. E.; Barbee, B. D.; Richards, J. H.; Butenhoff, J. L.; Stevenson, L. A.; Lau, C. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations Toxicol. Sci. 2003, 74, 369-381
13. Lau, C.; Thibodeaux, J. R.; Hanson, R. G.; Rogers, J. M.; Grey, B. E.; Stanton, M. E.; Butenhoff, J. L.; Stevenson, L. A. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation Toxicol. Sci. 2003, 74, 382-392
14. Andersen, M. E.; Butenhoff, J. L.; Chang, S.-C.; Farrar, D. G.; Kennedy, G. L., Jr.; Lau, C.; Olsen, G. W.; Seed, J.; Wallacekj, K. B. Perfluoroalkyl acids and related chemistries-Toxicokinetics and modes of action Toxicol. Sci. 2008, 102, 3-14
15. DeWitt, J. C.; Shnyra, A.; Badr, M. Z.; Loveless, S. E.; Hoban, D.; Frame, S. R.; Cunard, R.; Anderson, S. E.; Meade, B. J.; Peden-Adams, M. M.; Luebke, R. W.; Luster, M. I. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha Crit. Rev. Toxicol. 2009, 39, 76-94
16. Liu, C.; Du, Y.; Zhou, B. Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes Aquat. Toxicol. 2007, 85, 267-277
17. Tilton, S. C.; Orner, G. A.; Benninghoff, A. D.; Carpenter, H. M.; Hendricks, J. D.; Pereira, C. B.; Williams, D. E. Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout Environ. Health Perspect. 2008, 116, 1047-1055
18. Benninghoff, A. D.; Bisson, W. H.; Koch, D. C.; Ehresman, D. J.; Kolluri, S. K.; William, D. E. Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro Toxicol. Sci. 2011, 120, 42-58
19. Gao, Y.; Li, X.; Guo, L.-H. Assessment of estrogenic activity of perfluoroalkyl acids based on ligand-induced conformation state of human estrogen receptor Environ. Sci. Technol. 2013, 47, 634-641
20. Jones, P. D.; Hu, W. Y.; De Coen, W.; Newsted, J. L.; Giesy, J. P. Binding of perfluorinated fatty acids to serum proteins Environ. Toxicol. Chem. 2003, 22, 2639-2649
21. Han, X.; Snow, T. A.; Kemper, R. A.; Jepson, G. W. Binding of perfluorooctanoic acid to rat and human plasma proteins Chem. Res. Toxicol. 2003, 16, 775-781
22. Bischel, H. N.; MacManus-Spencer, L. A.; Luthy, R. G. Noncovalent interactions of long-chain perfluoroalkyl acids with serum albumin Environ. Sci. Technol. 2010, 44, 5263-5269
23. Chen, Y.-M.; Guo, L.-H. Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin Arch. Toxicol. 2009, 83, 255-261
24. Chang, S.-C.; Thibodeaux, J. R.; Eastvold, M. L.; Ehresman, D. J.; Bjork, J. A.; Froehlich, J. W.; Lau, C. S.; Singh, R. J.; Wallace, K. B.; Butenhoff, J. L. Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS) Toxicology 2007, 234, 21-33
25. De Geronimo, E.; Hagan, R. M.; Wilton, D. C.; Corsico, B. Natural ligand binding and transfer from liver fatty acid binding protein (LFABP) to membranes Biochim. Biophys. Acta 2010, 1801, 1082-1089
26. Wu, Y. L.; Peng, X. E.; Wang, D.; Chen, W. N.; Lin, X. Human liver fatty acid binding protein (hFABP1) gene is regulated by liver-enriched transcription factors HNF3beta and C/EBPalpha Biochimie 2012, 94, 384-392
27. Luebker, D. J.; Hansen, K. J.; Bass, N. M.; Butenhoff, J. L.; Seacat, A. M. Interactions of flurochemicals with rat liver fatty acid-binding protein Toxicology 2002, 176, 175-185
28. Rosen, M. B.; Lau, C.; Corton, J. C. Does exposure to perfluoroalkyl acids present a risk to human health? Toxicol. Sci. 2009, 111, 1-3
29. Cronet, P.; Petersen, J. F. W.; Folmer, R.; Blomberg, N.; Sjoblom, K.; Karlsson, U.; Lindstedt, E. L.; Bamberg, K. Structure of the PPAR alpha and -gamma ligand binding domain in complex with AZ 242; Ligand selectivity and agonist activation in the PPAR family Structure 2001, 9, 699-706
30. Thompson, J.; Winter, N.; Terwey, D.; Bratt, J.; Banaszak, L. The crystal structure of the liver fatty acid-binding protein-A complex with two bound oleates J. Biol. Chem. 1997, 272 (11) 7140-7150
31. Hostetler, H. A.; Petrescu, A. D.; Kier, A. B.; Schroeder, F. Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands J. Biol. Chem. 2005, 280, 18667-18682
32. Sharma, A. Fatty acid induced remodeling within the human liver fatty acid-binding protein J. Biol. Chem. 2011, 286, 31924-31928
33. Chattopadhyay, A.; Mukherjee, S.; Raghuraman, H. Reverse micellar organization and dynamics: A wavelength-selective fluorescence approach J. Phys. Chem. B 2002, 106, 13002-13009
34. Schroeder, F.; Myerspayne, S. C.; Billheimer, J. T.; Wood, W. G. Probing the ligand-binding sites of fatty-acid and sterol carrier proteins-effects of ethanol Biochemistry 1995, 34, 11919-11927
35. Hanhoff, T.; Lucke, C.; Spener, F. Insights into binding of fatty acids by fatty acid binding proteins Mol. Cell. Biochem. 2002, 239, 45-54
36. Nemecz, G.; Jefferson, J. R.; Schroeder, F. Polyene fatty-acid interactions with recombinant intestinal and liver fatty acid-binding proteins-spectroscopic studies J. Biol. Chem. 1991, 266, 17112-17123
37. Rolf, B.; Oudenampsen-Kruger, E.; Borchers, T.; Faergeman, N. J.; Knudsen, J.; Lezius, A.; Spener, F. Analysis of the ligand binding properties of recombinant bovine liver-type fatty acid binding protein Biochim. Biophys. Acta 1995, 1259, 245-253
38. Veerkamp, J. H.; van Moerkerk, H. T. B.; Prinsen, C. F. M.; van Kuppevelt, T. H. Structural and functional studies on different human FABP types Mol. Cell. Biochem. 1999, 192, 137-142
39. Velkov, T. Interactions between human liver fatty acid binding protein and peroxisome proliferator activated receptor selective drugs PPAR Res. 2013, 10.1155/2013/938401
40. Yang, J. T.; Wu, C. S. C.; Martinez, H. M. Calculation of protein conformation from circular-dichroism Methods Enzymol. 1986, 130, 208-269
41. Krafft, M. P.; Riess, J. G. Chemistry, physical chemistry, and uses of molecular fluorocarbon-hydrocarbon diblocks, triblocks, and related compounds-unique ″apblar″ components for self-assembled colloid and interface engineering Chem. Rev. 2009, 109, 1714-1792
42. Alfred, E. A.; Thumser, D. C. W. The binding of cholesterol and bile salts to recombinant rat liver fatty acid-binding protein Biochem. J. 1996, 320, 729-733
43. Iozzo, P.; Bucci, M.; Roivainen, A.; Nagren, K.; Jarvisalo, M. J.; Kiss, J.; Guiducci, L.; Fielding, B.; Naum, A. G.; Borra, R.; Virtanen, K.; Savunen, T.; Salvadori, P. A.; Ferrannini, E.; Knuuti, J.; Nuutila, P. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals Gastroenterology 2010, 139 (846-856) 856 e1-6
44. Shorten, P. R.; Upreti, G. C. A mathematical model of fatty acid metabolism and VLDL assembly in human liver Biochim. Biophys. Acta 2005, 1736, 94-108
45. Olsen, G. W.; Hansen, K. J.; Stevenson, L. A.; Burris, J. M.; Mandel, J. H. Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals Environ. Sci. Technol. 2003, 37, 888-891
46. Maestri, L.; Negri, S.; Ferrari, M.; Ghittori, S.; Fabris, F.; Danesino, P.; Imbriani, M. Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry Rapid Commun. Mass Spectrom. 2006, 20, 2728-2734
47. Olsen, G. W.; Burris, J. M.; Burlew, M. M.; Mandel, J. H. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations J. Occup. Environ. Med. 2003, 45, 260-270
48. Armitage, J. M.; Arnot, J. A.; Wania, F. Potential role of phospholipids in determining the internal tissue distribution of perfluoroalkyl acids in biota Environ. Sci. Technol. 2012, 46, 12285-12286
49. Hostetler, H. A.; McIntosh, A. L.; Atshaves, B. P.; Storey, S. M.; Payne, H. R.; Kier, A. B.; Schroeder, F. L-FABP directly interacts with PPARalpha in cultured primary hepatocytes J. Lipid Res. 2009, 50, 1663-1675
50. Wolfrum, C.; Borrmann, C. M.; Borchers, T.; Spener, F. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha-and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 2323-2328
51. Francis, G. A.; Fayard, E.; Picard, F.; Auwerx, J. Nuclear receptors and the control of metabolism Annu. Rev. Physiol. 2003, 65, 261-311
52. Mangelsdorf, D. J.; Evans, R. M. The RXR heterodimers and orphan receptors Cell 1995, 83, 841-850
53. Liberato, M. V.; Nascimento, A. S.; Ayers, S. D.; Lin, J. Z.; Cvoro, A.; Silveira, R. L.; Martinez, L.; Souza, P. C. T.; Saidemberg, D.; Deng, T.; Amato, A. A.; Togashi, M.; Hsueh, W. A.; Phillips, K.; Palma, M. S.; Neves, F. A. R.; Skaf, M. S.; Webb, P.; Polikarpov, I. Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) gamma activators and pan-PPAR partial agonists PLoS One 2012, 7, e36297